Gremio will be looking to climb out of the relegation zone when they welcome Sao Paulo to Arena do Gremio on Saturday for round 22 of the 2026 Brasileiro. The hosts head into the contest after midweek ...

CR Flamengo will host São Paulo FC in one of Brazilian football’s fiercest rivalries on Sunday, with kickoff set for 5:30 p.m. EDT at the Maracanã in Rio de Janeiro. Throughout the week, Pedro’s ...

The TV channel and live stream options for Flamengo vs Sao Paulo are listed below. Fanatiz and Premiere are both carrying the match, with links to watch live available for each service. Flamengo host ...

Today's game between Sao Paulo and Athletico Paranaense will kick-off at Jul 22, 2026, 8:30 PM. Sao Paulo host Athletico Paranaense in a Serie A fixture that carries real weight for both clubs as the ...

Sao Paulo welcome Athletico-PR to the Estadio Cicero de Souza Marques on Thursday's Brasileiro fixture, with the match moved from the Morumbis due to a series of Harry Styles concerts at the stadium.

Usama Mehmood is a Senior Writer at DualShockers with more than five years of experience in the video game industry. He has been writing professionally since 2021 and covering games since 2022, with ...

Bandai Namco released the full opening cinematic for Echoes of Aincrad on Tuesday, featuring the game's theme song "Live to Survive" by Japanese artist Aimer — the same video players will see when ...

Joshua started at GameRant in 2017 where he fell in love with a company that supports creativity, treats video games with the respect they deserve, and is complete with people whose passions match his ...

Trial design randomized 175 symptomatic oHCM patients (NYHA II–III; LVOT gradient ≥30 mm Hg rest or ≥50 mm Hg Valsalva) to titrated aficamten 5–20 mg or metoprolol 50–200 mg for 24 weeks. Across 16 ...

Echoes of Aincrad puts players in a situation that isn’t all that dissimilar from a lot of Sword Art Online named characters as they return to SAO for the full launch after the beta. Our character ...

Cytokinetics (CYTK) stock surged Tuesday on positive results in a heart disease study where its chief rival, Bristol Myers Squibb's (BMY) Camzyos, previously failed. The study, dubbed Acacia-HCM, ...

In the ACACIA-HCM trial, aficamten demonstrated a statistically significant improvement over placebo in both KCCQ-CSS (P =.021) and pVO2 (P =.003) at 36 weeks, with no new safety signals observed.